RxDoctor Payments Data

Scott Mallozzi, MD

Orthopaedic Surgery · Providence, RINPI 1508127895

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Alphatec Spine, Inc at 57.7% of the total. Reporting peaked in 2022 at $10,047 and has fallen 79.9% since, to $2,022 in 2025.

$27,930in general payments, 2019–2025

Across 83 payments — averaging $336.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$16K
  • Spine Wave, Inc.$4K
  • Spineart USA Inc$4K
  • Stryker$3K
  • Augmedics Inc.$371
  • Johnson & Johnson$287
  • plus $418 from 7 others

What the payments were for

  • Consulting fees$7,00025%
  • Travel & lodging$14,40152%
  • Food & beverage$6,53023%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,930 in reported general payments places this provider in the 80th percentile of 124 orthopaedic surgery providers in Rhode Island.

See all orthopaedic surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$123,004
Medicare patients
148
Services billed
466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin18$271
Tramadol Hcl31$134
Methocarbamol14$121
Prednisone11$53

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →